Systemic and topical immunoglobulin treatment in immunocompromised patients.
Hammarström
L
L
Dept of Clinical Immunology, Huddinge University Hospital, Sweden.
Gardulf
A
A
Hammarström
V
V
Janson
A
A
Lindberg
K
K
Smith
C I
CI
D000287:Administration, Topical; D000818:Animals; D001327:Autoimmune Diseases / Q000628:therapy*; D006801:Humans; D016867:Immunocompromised Host; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D007153:Immunologic Deficiency Syndromes / Q000628:therapy; D007239:Infections / Q000628:therapy*; D005719:gamma-Globulins / Q000627:therapeutic use
D016756:Immunoglobulins, Intravenous; D005719:gamma-Globulins